TrialThe British journal of ophthalmology2022

Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study.

Kun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.